2024 Reports Addiction
Report of the Citizens’ Assembly on Drugs Use. Volume I. Foreword, Executive Summary, Meetings Summary and Recommendations. January 2024
Report of the Citizens’ Assembly on Drugs Use. Volume II. Record of Meetings, Results of Balloting, Appendices. January 2024
Pharmacy needle exchange programme: review of performance indicators. Drug Insights Report 4, Evans D, Keenan E. National Social Inclusion Office, Health Service Executive. Dublin, 2024.
2024 Academic Publications Addiction
A simple presumptive field test for nitrous oxide. Oakes C, Adnan A, Kavanagh P, McCormack S, Killeen N. Irish Journal of Medical Science (1971-).2024 Feb 7:1-2.
The emergence of nitazenes on the Irish heroin market and national preparation for possible future outbreaks. Killeen N, Lakes R, Webster M, Killoran S, McNamara S, Kavanagh P, Eagleton M, McCormack S, Micheau E, Moughty A, O'Donnell C. Addiction (Abingdon, England). 2024 May 8.
Gabapentinoids in Ireland 2010 to 2020: An observational study of trends in gabapentinoid prescribing, law enforcement drug seizures and postmortem toxicology. Durand L, O'Kane A, Tierney J, Cronly M, Bennett KE, Kavanagh Y, Keenan E, Cousins G. British journal of clinical pharmacology. 2024 Apr;90(4):987-95.
Re-evaluation of the numbers of people involved in substance misuse in Ireland using the National Drug Treatment Reporting System (NDTRS) and the Central Treatment List (CTL). Evans DS, Keenan E. Irish Journal of Medical Science (1971-). 2024 Feb;193(1):1-2.
Commercial Tobacco Endgame Goals: Early Experiences From Six Countries. Nip J, Thornley L, Schwartz R, Cunningham R, Hara M, Clancy L, Evans D, Howell F, Duffy S, Gilljam H, Edwards R. Nicotine and Tobacco Research. 2024 Mar 28:ntae069.
Community Pharmacy Needle Exchange Programme: What Can Analysis of the Data Tell Us about the Changing Drug Market in Ireland? Evans DS, Harnedy N, Keenan E. International Journal of Environmental Research and Public Health. 2024 Mar 1;21(3):289.
2023 Reports Addiction
Drug Treatment in Ireland: Key Patterns and Trends; 2014-2021, Drug Insights Report 3, Evans D, Keenan E. National Social Inclusion Office, Health Service Executive. Dublin, 2023.
HSE emerging drug trend monitoring. Year 2 results from the Syringe Analysis Programme 2022, The identification of injecting trends in the Dublin and Midland Region through the application of syringe analysis methodology, McNamara, S., Killeen, N., Eagleton, M., & Keenan, E. Health Service Executive, Dublin, 2023
The HSE ‘Safer Nightlife’ Programme 2022, Volunteer feedback on the provision of harm reduction outreach in Irish festival settings. Killeen, N., Corrigan, N. & Keenan, E. Health Service Executive, Dublin, 2023.
2023 Academic Publications Addiction
‘K culture’, ketamine’s prominent yet overlooked role on the Irish drug scene and implications for health. Killeen N, Mc Namara S, Keenan E. Irish Journal of Medical Science (1971-). 2023 Dec 16:1-3.
The Implementation of Quality Standards (QS) at Coolmine Therapeutic Community. Coughlan E, Mckeown P, Corrigan N, Harris A. Addictology/Adiktologie. 2023 Jan 1(1).
Prescription drugs with potential for misuse in Irish prisons: analysis of national prison prescribing trends, by gender and history of opioid use disorder, 2012 to 2020. Durand L, Keenan E, O’Reilly D, Bennett K, O’Hara A, Cousins G. BMC psychiatry. 2023 Oct 6;23(1):725.
An overview of recent advances in opioid agonist treatment (OAT). McNicholas M, Scully M, Keenan E. Irish Journal of Psychological Medicine. 2023 Sep;40(3):535-7.
Impact of changes to the delivery of opioid agonist treatment, introduced during the COVID-19 pandemic, on treatment access and dropout in Ireland: An interrupted time series analysis. Durand L, Boland F, Harnedy N, Delargy Í, Scully M, Bourke M, Ebbitt W, Vázquez MO, Keenan E, Cousins G. Journal of Substance Use and Addiction Treatment. 2023 Jun 1;149:209029.
Impact of COVID-19 & response measures on HIV-HCV prevention services and social determinants in people who inject drugs in 13 sites with recent HIV outbreaks in Europe, North America and Israel. Wiessing L, Sypsa V, Abagiu AO, Arble A, Berndt N, Bosch A, Buskin S, Chemtob D, Combs B, Conyngham C, Feelemyer J. AIDS and Behavior. 2023 Apr;27(4):1140-53.
Prescription drugs with potential for misuse: protocol for a multi-indicator analysis of supply, detection and the associated health burden in Ireland between 2010 and 2020. Cousins G, Durand L, O’Kane A, Tierney J, Maguire R, Stokes S, O’Reilly D, Arensman E, Bennett KE, Vázquez MO, Corcoran P. BMJ open. 2023 Mar 1;13(3):e069665.
Deterrence effect of penalties upon adolescent cannabis use. Smyth BP, Davey A, Keenan E. Irish Journal of Psychological Medicine. 2023 Feb 16:1-6.
2022 Reports Addiction
Naloxone Administration by Addiction and Homeless Service providers in Ireland: 2018-2020, Drug Insights Report 2, Evans D, Bingham T, Hamza S, Keenan E. National Social Inclusion Office, Health Service Executive. Dublin, 2022.
HSE naloxone drug insights report infographic
European Web Survey on Drugs 2021: Irish Results. Mongan, D., Killeen, N., Evans, D., Millar, S.R., Keenan, E. & Galvin, B. Health Research Board. Dublin, 2022.
Safer Nightlife Programme 2022. Results from ‘back of house’ drug testing. Killeen, N., Mc Namara, S., Stokes, S. and Keenan, E. Health Service Executive, 2022.
Recreational use of nitrous oxide: a growing concern for Europe. van Aerts L, de Morais J, Evans-Brown M, Jorge R, Gallegos A, Christie R, Néfau T, Planchuelo G, Sedefov R. European Monitoring Centre for Drugs and Drug Addiction, 2022
Irish Syringe Analysis Pilot Project, The identification of current injecting trends in the Dublin and Midland Region through the application of syringe analysis methodology. McNamara, S., Killeen, N., Stokes, S., & Keenan, E. Health Service Executive, Dublin, 2022.
Development of an outcome framework for SAOR screening and brief intervention or substance use as part of the health diversion programme. Shorter, G.W., Corrigan, N., Keenan, E., Percy, A. Health Service Executive, Dublin, 2022.
2022 Academic Publications Addiction
A systematized review of drug-checking and related considerations for implementation as a harm reduction intervention. Giulini F, Keenan E, Killeen N, Ivers JH. Journal of Psychoactive Drugs. 2023 Jan 1;55(1):85-93.
Consensus recommendations for opioid agonist treatment following the introduction of emergency clinical guidelines in Ireland during the COVID-19 pandemic: a national Delphi study. Durand L, Keenan E, Boland F, Harnedy N, Delargy Í, Scully M, Mayock P, Ebbitt W, Vázquez MO, Corrigan N, Killeen N. International Journal of Drug Policy. 2022 Aug 1;106:103768.
Development of quality indicators for the continued and safe delivery of Opioid Agonist Treatment (OAT), throughout and beyond COVID-19, using a Delphi Consensus technique. Cousins G, Durand L, Boland F, Harnedy N, Delargy Í, Scully M, Bourke M, Ebbitt W, Otero Vázquez M, Mayock P, Corrigan N. HRB Open Research. 2021 Aug 18;4:90.
2021 Reports Addiction
Drug Related Deaths in Ireland: Key Patterns and Trends 2008-2017, Drug Insights Report 1. Evans D, Keenan E, Killeen N. National Social inclusion Office, Health Service Executive. Dublin, 2021
Drug Related Deaths in Ireland Infographic
Report of the Emerging Drug Trend and Drug Checking Working Group. Keenan, E., Killeen, N. and The Emerging Drug Trends and Drug Checking Working Group. Health Service Executive, Dublin, 2021.
2021 Academic Publications Addiction
Drug use, harm-reduction practices and attitudes toward the utilisation of drug safety testing services in an Irish cohort of festival attendees. Ivers JH, Killeen N, Keenan E. Irish Journal of Medical Science (1971-). 2021 Sep 20:1-0.
Therapeutic potential of long-acting opioids and opioid antagonists for SARS-CoV-2 infection. Eagleton M, Stokes S, Fenton F, Keenan E. British Journal of Anaesthesia. 2021 Dec 1;127(6):e212-4. https://pubmed.ncbi.nlm.nih.gov/34556330/
Does opioid substitution treatment have a protective effect on the clinical manifestations of COVID-19? Comment on Br J Anaesth 2020; 125: e382-3. Eagleton M, Stokes S, Fenton F, Keenan E. British Journal of Anaesthesia. 2021 Mar 1;126(3):e114-6.
Factors associated with early and later dropout from methadone maintenance treatment in specialist addiction clinics: a six-year cohort study using proportional hazards frailty models for recurrent treatment episodes. Durand L, Boland F, O’Driscoll D, Bennett K, Barry J, Keenan E, Fahey T, Cousins G. Drug and Alcohol Dependence. 2021 Feb 1;219:108466.
2020 Academic Publications Addiction
Do interruptions to the continuity of methadone maintenance treatment in specialist addiction settings increase the risk of drug-related poisoning deaths? A retrospective cohort study. Durand L, O'Driscoll D, Boland F, Keenan E, Ryan BK, Barry J, Bennett K, Fahey T, Cousins G.. Addiction. 2020 Oct;115(10):1867-77.
HIV outbreaks among people who inject drugs in Europe, North America, and Israel. Des Jarlais DC, Sypsa V, Feelemyer J, Abagiu AO, Arendt V, Broz D, Chemtob D, Seguin-Devaux C, Duwve JM, Fitzgerald M, Goldberg DJ. HIV outbreaks among people who inject drugs in Europe, North America, and Israel. The Lancet HIV. 2020 Jun 1;7(6):e434-42.
2018 Reports Addiction
National Summary of the Service User Experience Survey 2017. HSE National Addiction Advisory Governance Group, HSE National Social Inclusion Office, 2018.
2018 Academic Publications Addiction
Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users. Klimas J, Fairgrieve C, Tobin H, Field CA, O'Gorman CS, Glynn LG, Keenan E, Saunders J, Bury G, Dunne C, Cullen W. Cochrane Database of Systematic Reviews. 2018(12): CD009269
Barriers to progressing through a methadone maintenance treatment programme: perspectives of the clients in the Mid-West of Ireland's drug and alcohol services. Moran L, Keenan E, Elmusharaf K. BMC Health Services Research. 2018 Dec;18:1-5.
A naturalistic longitudinal analysis of post-detoxification outcomes in opioid-dependent patients. Ivers JH, Zgaga L, Sweeney B, Keenan E, Darker C, Smyth BP, Barry J. Drug and Alcohol Review. 2018 Apr;37:S339-47.
Trends in Injector Deaths in Ireland, as Recorded by the National Drug-Related Deaths Index, 1998-2014. Lynn TM, Lynn E, Keenan E, Lyons S. Journal of Studies on Alcohol and Drugs. 2018 Mar;79(2):286-92.
Chemsex, risk behaviours and sexually transmitted infections among men who have sex with men in Dublin, Ireland. Glynn RW, Byrne N, O’Dea S, Shanley A, Codd M, Keenan E, Ward M, Igoe D, Clarke S. International Journal of Drug Policy. 2018 Feb 1;52:9-15.
Progressive white matter impairment as a predictor of outcome in a cohort of opioid-dependent patient's post-detoxification. Ivers JH, Fitzgerald J, Whelan C, Sweeney B, Keenan E, Fagan A, McMarrow J, Meany J, Barry J, Frodl T. Addiction Biology. 2018 Jan;23(1):304-12.
